Literature DB >> 1705245

Identification of a surface-exposed immunodominant epitope on outer membrane protein P1 of Haemophilus influenzae type b.

C Proulx1, R S Munson, S Grass, J Hamel, D Martin, B R Brodeur.   

Abstract

Eight murine monoclonal antibodies (MAbs) directed against outer membrane protein P1 of Haemophilus influenzae type b were generated and characterized. Seven of the eight MAbs reacted with recombinant P1 and purified P1 protein from H. influenzae type b strains MinnA and 1613; MAb P1.8 was specific for the latter strain. A panel of 32 nontypeable and 140 encapsulated Haemophilus strains recovered worldwide representing the major clonal families of serotypes a, b, and d was used to evaluate the distribution among Haemophilus strains of the epitopes identified by the P1-specific MAbs. The epitope reactive with the seven MAbs which recognized P1 from strains MinnA and 1613 was shared by 92% of the encapsulated Haemophilus isolates tested. The epitope is present in the H. influenzae type b strains from clonal families commonly recovered from cases of invasive disease in North America and Europe. A series of nested 5' and 3' deletions of the P1 gene were constructed and analyzed to localize the determinants on P1 recognized by the MAbs. MAbs P1.2, P1.4, P1.5, P1.6, and P1.7 recognized an epitope localized to the carboxy-terminal portion of P1. Murine MAbs P1.1 and P1.3 and two human MAbs, HiH-7 and HiH-10, recognized a complex epitope which was partially localized to the carboxy-terminal portion of the P1 protein. These data indicate that an immunodominant surface-exposed epitope is present on the carboxy-terminal portion of the P1 protein of type b Haemophilus isolates responsible for the majority of invasive disease in North America.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705245      PMCID: PMC258353          DOI: 10.1128/iai.59.3.963-970.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Antigenic relationships among the porin proteins of encapsulated Haemophilus influenzae clones.

Authors:  D Martin; J Hamel; B R Brodeur; J M Musser
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

2.  Isolation and characterization of a mutant of Haemophilus influenzae type b deficient in outer membrane protein P1.

Authors:  R Munson; A Hunt
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Heterohybridomas secreting human monoclonal antibodies against Haemophilus influenzae type b.

Authors:  D Martin; Y Larose; J Hamel; J Lagacé; B R Brodeur
Journal:  Eur J Immunol       Date:  1988-04       Impact factor: 5.532

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Immunoprotection of rats against Haemophilus influenzae type B disease mediated by monoclonal antibody against a haemophilus outer-membrane protein.

Authors:  E J Hansen; S M Robertson; P A Gulig; C F Frisch; E J Haanes
Journal:  Lancet       Date:  1982-02-13       Impact factor: 79.321

6.  Subtyping isolates of Haemophilus influenzae type b by outer-membrane protein profiles.

Authors:  S J Barenkamp; R S Munson; D M Granoff
Journal:  J Infect Dis       Date:  1981-05       Impact factor: 5.226

7.  Outer-membrane protein subtypes of Haemophilus influenzae type b and spread of disease in day-care centers.

Authors:  S J Barenkamp; D M Granoff; R S Munson
Journal:  J Infect Dis       Date:  1981-09       Impact factor: 5.226

8.  Protection of infant rats from Haemophilus influenzae type b infection by antiserum to purified outer membrane protein a.

Authors:  M R Loeb
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

9.  Prospects for prevention of Haemophilus influenzae type b disease by immunization.

Authors:  D M Granoff; R S Munson
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

10.  Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody.

Authors:  B R Brodeur; Y Larose; P Tsang; J Hamel; F Ashton; A Ryan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

View more
  6 in total

1.  Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis.

Authors:  D Martin; M S Peppler; B R Brodeur
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

2.  Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach.

Authors:  G R Bolduc; V Bouchet; R Z Jiang; J Geisselsoder; Q C Truong-Bolduc; P A Rice; S I Pelton; R Goldstein
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  Identification of surface-exposed B-cell epitopes recognized by Haemophilus influenzae type b P1-specific monoclonal antibodies.

Authors:  H Panezutti; O James; E J Hansen; Y Choi; R E Harkness; M H Klein; P Chong
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

4.  Conservation of immune responses to proteins isolated by preparative polyacrylamide gel electrophoresis from the outer membrane of nontypeable Haemophilus influenzae.

Authors:  J M Kyd; D Taylor; A W Cripps
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

5.  Immunogenicity of synthetic peptides of Haemophilus influenzae type b outer membrane protein P1.

Authors:  P Chong; Y P Yang; D Persaud; M Haer; B Tripet; E Tam; C Sia; M Klein
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

6.  Positively selected codons in immune-exposed loops of the vaccine candidate OMP-P1 of Haemophilus influenzae.

Authors:  Ted H M Mes; Jos P M van Putten
Journal:  J Mol Evol       Date:  2007-03-19       Impact factor: 2.395

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.